Kaia Health has just announced a $75 million funding round for its technology, aimed at improving musculoskeletal (MSK) The post Kaia Health gets $75m for digital...
Kaia Health has raised a further $75m to expand its AI-based treatment for Musculoskeletal (MSK) and chronic obstructive The post Kaia Health raises $75m for digital...
When combined with drugs currently used to treat hepatitis C, the antiviral remdesivir is 10 times more effective in treating cells infected with SARS-CoV-2.
Shares of Ocugen Inc shot up by 15.6% in pre-market trading on Monday as the company announced the sale of 10 million shares to institutional investors...
Credit: UK HealthCare Marketing LEXINGTON, Ky. (April 26, 2021) — From Kentucky farms to University of Kentucky labs and now to Kentucky patients, the UK Markey...
Clinical trial will evaluate safety and psychoactive properties of natural Psilocybin product extracted and formulated at 7,000-square-foot laboratory in British Columbia, Canada Numinus Wellness Inc. (“Numinus”...
Consumer spending has long been the engine of the US economy, which is what made the social lockdown policies put in place against COVID so devastating....
A scholar of Greek literature writes why we need to turn to the past to understand the present – and the lessons that Homer's hero, Odysseus,...
Roche has axed two mid-stage COVID drugs from its development pipeline, according to a first quarter results statement The post Roche axes two pipeline COVID drugs...
Credit: NIAID A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild...
TORONTO – New Leaf Canada Inc. reported it has received approval from Health Canada that will allow its wholly-owned subsidiary Psirenity to begin construction of a...
Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just The post NICE says yes to Novartis’ multiple...
Johnson & Johnson is slated to report first-quarter 2021 earnings on April 20 before the market opens. Over the past six months, shares of the medical...
BioElectronics Corp. (OTCPINK: BIEL) is heating up again in recent trading and looking to break out northbound again. Microcapdaily has been reporting on BIEL for years and covered them...
Less than a month after submitting an Investigational New Drug (IND) application, Anixa Biosciences ran into a snag with the U.S. Food and Drug Administration as the government...
Combating catastrophic demoralization and suicidal thoughts during COVID-19 means supporting people to reconnect with their values, with meaning in life and with others.
Acting FDA Commissioner Janet Woodcock shared her thoughts on pandemic issues and outlined FDA modernization plans in a Q&A session with the Alliance for a Stronger...
Acting FDA Commissioner Janet Woodcock shared her thoughts on pandemic issues and outlined FDA modernization plans in a Q&A session with the Alliance for a Stronger...
NICE has included proposals to speed up evaluations and focus on new technology such as digital health in The post NICE unveils five year plan promising...
UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last The post Clive Dix: Rebuilding UK biotech appeared...
New funding: 2Morrow, a Seattle-area startup that develops digital coaching software to help people reach health goals, has raised $1.5 million. Total funding to date is...
World Psychedelics Day (WPD), launches Sunday, June 20th celebrating a new era of informed perspectives on modern-day psychedelics and breakthroughs in treatment of mental health.
A lack of emotional support within the police is leading to PTSD and burnout.
Eli Lilly requested cancellation of the U.S. authorization granted to the company's Covid-19 antibody bamlanivimab, which will now be used in combination with another to achieve...
IQVIA’s Sarah Rickwood reviews the launch of innovative medicines in 2020 and outlines three key pillars of activity The post Three pillars of post-pandemic launch excellence...
2021 ARRS Virtual Annual Meeting research finds in the setting of high pretest probability of COVID-19 infection or with quick turnaround of rapid RT-PCR COVID-19 test,...
So, you have decided it is time to get in on the investing game. Rest assured, you are not alone. Since November, investors have parked $569...
When it comes to developing cutting-edge innovations, Astellas aims to be at the forefront. The pharma organisation prides The post Global impact: How regulatory affairs is...
Bouncing back with incredible force, the S&P 500 has gained 50% over the past 12 months, with the index now landing just shy of its 52-week...
Credit: NTU People who have recovered from COVID-19, especially those with pre-existing cardiovascular conditions, may be at risk of developing blood clots due to a lingering...